FDA Inspection 971871 — Institute for Reproductive Health

Institute for Reproductive Health — FEI 3004562849

The FDA completed an inspection of Institute for Reproductive Health on May 25, 2016 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 25, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Cincinnati, OH (United States)